期刊文献+

应用mRNA差异显示技术筛选子宫内膜癌相关基因片段 被引量:2

Application of mRNA differential display technique in screening related gene of endometrial carcinoma
原文传递
导出
摘要 目的 应用mRNA差异显示技术 ,筛选子宫内膜癌的相关基因片段。方法 提取同一患者的正常子宫内膜和子宫内膜癌组织总RNA ,行差异显示 聚合酶链反应 (DD PCR)技术 ,扩增产物在测序胶上电泳 ,经银染分离筛选差异条带并测序 ,用BLAST基因数据库进行分析。结果 有 2条基因片段与已知人类基因片段同源性低或无同源性 ,自定义为T1 7,T1 7基因片段登陆号为AF315 5 81;另 2条基因片段与已知基因片段同源性高达 97 3%和 85 0 %。T1 7基因片段在子宫内膜癌组织中呈高表达 ,在增生的子宫内膜组织中呈低表达 ,在正常子宫内膜组织中不表达。结论 T1 7基因片段可能为子宫内膜癌新的相关基因片段。 Objective To screen related gene of endometrial cancer by mRNA differential display (DD) polymerase chain reaction (PCR). Methods Individual mRNA from normal and neoplastic endometrium obtained from the same patient were comparatively studied by DD methodology.The mRNAs were isolated from the tissues, reverse transcribed to cDNA, and then amplified by PCR. The PCR products were displayed on a polyacrylamid gel by silver staining, and the differentially expressed bands were retrieved and reamplified. Subsequently we selected four bands for sequencing and making further investigation. Results cDNA homology was analysed by searching through GenBank sequence databases and indicated that tumor fragment (T1 7) has no significant sequence homology with any sequence of known function. Acession number is AF315581. Further study showed that T1 7 expressed more abundantly in endometrial cancer than hyperplasia endometrium, but not expressed in normal endometrium. Conclusions T1.7 is a new expressed sequence tag. It may be related gene fragment of endometrial cancer.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2001年第6期364-367,W001,共5页 Chinese Journal of Obstetrics and Gynecology
关键词 子宫内膜肿瘤 原位杂交 mRNA差异 诊断 基因片段 Endometrial neoplasms Investigative technigues In situ hybridization
  • 相关文献

参考文献5

  • 1Elvira C,Gynecol Oncol,1996年,63卷,228页
  • 2Walmer D K,Cancer Res,1995年,55卷,1168页
  • 3Altschul S,Nature Genetics,1994年,6卷,119页
  • 4Sasaki H,Cancer Res,1993年,53卷,1906页
  • 5Liang P,Science,1992年,257卷,967页

同被引文献29

  • 1Almog B,Gamzu R,Kuperminc MJ,et al. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia. Gynecol Oncol,2003,88 ( 3 ) :345.
  • 2Pilch H, Hoehn H, Schmidt M, et al. CD8 + CD45RA + CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8 + T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7. Zentralbl Gynakol,2002,124 (8 -9) :406.
  • 3Frost M, Bobak JB, Gianani R, et al. Localization of telomerase hTERT protein and HTR in benign mucosa,dysplasia and squamous cell carcinoma of cervix. Am J Clin Pathol,2000,114 (5) :726.
  • 4Reddy VG, Khanma N, Jain SK, et al. Telomerase-A molecular marker for cervical cancer screening. Int J Gynecol Cancer,2001,11(2):100.
  • 5Bae DS,Cho SB,Kim YJ,et al. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol,2001,81 ( 1 ) :341.
  • 6Callagy G, O Grady A, Butler D. Expression of CD44 in uterine cervical squamous neoplasia: a predictor of microinvasion? Gynecol Oncol,2000,76 ( 1 ) :73.
  • 7Riethdorf L, Riethdorf S, Lee KR, et al. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. Hum Pathol,2002,33 (9) :899.
  • 8Shiozawa T,Shiohara S,Kanai M, et al. Expression of the cell cycle regulator p27( Kipl ) in normal squamous epithelium,cervical intraepithelial neoplasia, and invasive squamous cell carcinoma of the uterine cervix. Immunohistochemistry and functional aspects of p27( Kipl ). Cancer,2001,92 ( 12 ) :3005.
  • 9Miturski R, Bogusiewicz M, Ciotta C, et al. Mismatch repair genes and microsatellite instability as molecular markers for gynecological cancer detection. Exp Biol Med ,2002,227 (8) :579.
  • 10Brustmann H, Navde S. Expression of topoisomerase II alpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleo-lar organizer regions in vulvar squamous lesions. Gynecol Oncol,2002,86(2) :192.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部